Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 33, 2009 - Issue 6
104
Views
4
CrossRef citations to date
0
Altmetric
Short Communications

Hb Sallanches [α104(G11)Cys→Tyr, TGC>TAC] Occurs Frequently on the Indian Subcontinent

, , , , , , & show all
Pages 486-491 | Received 03 Mar 2009, Accepted 16 May 2009, Published online: 03 Dec 2009
 

Abstract

Point mutations of α-globin genes in homozygous or in compound heterozygous states cause severe α-thalassemia (α-thal). Here we describe a polymerase chain reaction-restriction fragment length polymorphism-based method for easy detection of the point mutation Hb Sallanches [α104(G11)Cys→Tyr, TGC>TAC], earlier detected by a sequencing technique. In a cohort of 104 unrelated putative α-thal patients, nine carried the mutation and two were homozygotes. The mutation occurred on both the α2- or α1-globin genes. The phenotypes, in conjunction with other point mutations or deletions, are presented. Earlier detected in Pakistan and Punjab of India, it is probably present all over the Indian subcontinent.

ACKNOWLEDGMENTS

Financial assistance from the West Bengal Department of Science and Technology (A/F/814/4S/1984/2007) and University Grant Commission (UGC/194/UPE/2007/2) is acknowledged.

Declaration of Interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.